RhoVac Management
Management criteria checks 2/4
Actualmente no disponemos de información suficiente sobre el Director General.
Key information
Lars Hedbys
Chief executive officer
kr191.6k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO
Lars Hedbys (65 yo)
less than a year
Tenure
kr191,610
Compensation
Mr. Lars Hedbys, Ph. D., served as Director at Hamlet Pharma AB (publ) until 2022. He serves as Independent Chairman of the Board of Directors at Scandinavian ChemoTech AB (publ) since 2020. He serves as D...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Acting CEO & Director | 8yrs | kr191.61k | no data | |
Scientific Advisor & Co-Founder | no data | no data | no data | |
Director | 3yrs | kr191.61k | no data | |
Director | 8yrs | kr160.69k | no data | |
Chairman | 5yrs | kr383.22k | no data | |
Scientific Advisory Board | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
Scientific advisor | no data | no data | no data | |
Scientific Advisor | no data | no data | no data |
4.0yrs
Average Tenure
65.5yo
Average Age
Junta con experiencia: La junta directiva de RHOVAC se considera experimentada (4 años de antigüedad promedio).